Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | TENXTenax Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $0.00 |
| Revenue, yoy | — |
| Net income | $52.60M |
| Net income, yoy | −198.8% |
| Net margin | — |
| Free cash flow | $11.39M |
| FCF margin | — |
| EPS, diluted | $1.34 |
Add another company.